Boehringer Ingelheim Licenses DoubleTwist s CAT

Jun 20, 2001

NEW YORK, June 20- Boehringer Ingelheim has signed a multi-site license for DoubleTwist’s Clustering and Alignment Tools (CAT), the companies announced Wednesday.

DoubleTwist declined to reveal the financial details of the agreement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Second One From Kite

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Worth the Price?

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Beyond Counting Tree Rings

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

This Week in Nature

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.

Main menu